Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02596776 · ClinicalTrials.gov registry record · Early Phase 1

Cold Induced Changes in White Adipose

A Early Phase 1 study, sponsored by Philip Kern.

Completed
Registry status
Early Phase 1
Development phase
26
Enrollment target

NCT02596776 is a Early Phase 1 study that has completed, run by Philip Kern. The registered enrollment target is 26 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02596776, a Early Phase 1 study, has completed, sponsored by Philip Kern.

COMPLETED
Registry status
Early Phase 1
Development phase
26 participants
Enrollment target

Study Summary

An adaptation to a cold environment is a tendency to generate heat within our body. Some of this heat comes from our fat tissue. Although most fat tissue is "white fat", there are pockets deep within the body that are called "brown fat", which are specially adapted to burning fat and making heat. The investigator believes that our white fat, just underneath the surface of our skin, also has this property to burn fat and make heat, although not at the high level of brown fat. This study is to examine this fat-burning property of the white fat under the skin in response to seasons and to cold. Many such studies have been done in mice, but little has been done in humans. There are a number of factors, including age, weight, and medical history, that may make a person eligible or ineligible to participate in this study. Certain medications could make a person ineligible, but if these medications can be safely altered, the individual may become eligible.

Interventions

  • PROCEDURE Fat biopsy
  • DRUG Propranolol and fat biopsy
  • OTHER heavy water and fat biopsy

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2016-03
Est. Completion 2018-08-20
Phase Early Phase 1

Sponsor

Philip Kern

9 total trials

What the Registry Record Tells You About NCT02596776

The ClinicalTrials.gov registry entry for NCT02596776 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philip Kern, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Fat biopsy is the first listed.

NCT02596776 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02596776 about?

NCT02596776 is a clinical study titled "Cold Induced Changes in White Adipose". An adaptation to a cold environment is a tendency to generate heat within our body. Some of this heat comes from our fat tissue. Although most fat tissue is "white fat", there are pockets deep within the body that are called "brown fat", which are specially adapted to burning fat and making heat. Th...

What is the current status of trial NCT02596776?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 26 participants. The study started on 2016-03. Estimated completion is 2018-08-20.

What interventions are being tested in trial NCT02596776?

The interventions under investigation include: Fat biopsy (PROCEDURE), Propranolol and fat biopsy (DRUG), heavy water and fat biopsy (OTHER).

Who is sponsoring clinical trial NCT02596776?

This trial is sponsored by Philip Kern, which has 9 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.